Medication burden, characterized by polypharmacy and suboptimal treatment adherence, is a predictor for acute care use among ...

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help ...

When my father and his brothers all died of prostate cancer in the 1990s, it was still considered an “old man’s disease” and ...

If you know every public bathroom in town…If leaping out of bed to pee is routine…If you’d like a kinder, gentler treatment option for an enlarged prostate…keep reading.

The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...

Canada: A recent study published in Prostate Cancer and Prostatic Diseases sheds new light on the debated role of statins in prostate cancer prevention. Led by Dr. Ali Amiri from the Division ...

This common condition affects up to three million people in the UK each year – but chances are, you've not heard of it. Benign prostatic hyperplasia (BPH), otherwise referred to as an enlarged ...

In a world where cancer remains a formidable adversary, Mr Z's story serves as a poignant reminder of the importance of early intervention and the power of patient awareness. Don’t let the silence of ...

UniSA Lecturer in Pharmacy, Dr Natansh Modi.A major international study involving 23,000 people has found concerning evidence ...

Prescriptions for GLP-1 receptor agonists in cancer patients have increased despite lack of clinical guidance. The overall ...

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...

WASHINGTON — President Trump said Sunday that he planned to help the creator of the satirical comic strip “Dilbert” get access to a prostate cancer drug.